The functional anatomy of basal ganglia disorders, Trends Neurosci, vol.12, issue.10, pp.366-75, 1989. ,
Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions, Prog Brain Res, vol.85, pp.119-165, 1990. ,
Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson disease and non-arteric anterior optic ischemic neuropathy, Med Hypotheses, vol.47, issue.5, pp.413-417, 1996. ,
Helicobacter pylori and neurological diseases: Married by the laws of inflammation, World J Gastrointest Pathophysiol, vol.5, issue.4, pp.400-404, 2014. ,
Pharmacokineticspharmacodynamics of antimicrobial therapy: it's not just for mice anymore, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.44, issue.1, pp.79-86, 2007. ,
Is there a role for Mycobacterium avium subspecies paratuberculosis in Parkinson's disease?, J Neuroimmunol, vol.293, pp.86-90, 2016. ,
Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila, J Biol Chem, vol.280, issue.4, pp.2873-2881, 2005. ,
Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain, J Virol, 2015. ,
HIV dementia: the role of the basal ganglia and dopaminergic systems, J Psychopharmacol, vol.14, issue.3, pp.214-235, 2000. ,
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels, J Neurochem, vol.118, issue.6, pp.1043-55, 2011. ,
Rifampicin improves neuronal apoptosis in LPS-stimulated co-cultured BV2 cells through inhibition of the TLR-4 pathway, Mol Med Rep, vol.10, issue.4, pp.179-188, 2014. ,
Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation, Brain Res, vol.1395, pp.12-20, 2011. ,
Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats, Neurotoxicology, vol.44, pp.71-80, 2014. ,
Inhibition of West Nile Virus Multiplication in Cell Culture by Anti-Parkinsonian Drugs, Front Microbiol, vol.7, p.296, 2016. ,
Clinical potential of minocycline for neurodegenerative disorders, Neurobiol Dis, vol.17, issue.3, pp.359-66, 2004. ,
Adjuvants to L-dopa for Parkinsonism, Br Med J, vol.2, issue.5708, p.540, 1970. ,
The gut microbiota influences blood-brain barrier permeability in mice, Sci Transl Med, vol.6, issue.263, pp.263-158, 2014. ,
The association between infectious burden and Parkinson's disease: A case-control study, Parkinsonism Relat Disord, vol.21, issue.8, pp.877-81, 2015. ,
Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease, Ann Clin Transl Neurol, vol.2, issue.10, pp.949-59, 2015. ,
Association between Parkinson's Disease and Helicobacter Pylori, J Clin Neurol, vol.12, issue.2, pp.147-50, 2016. ,
Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome, Future Microbiol, vol.6, issue.5, pp.533-582, 2011. ,
Amantadine for the treatment of levodopa dyskinesias in Parkinson's disease ,
, Medicina (B Aires), vol.60, issue.3, pp.321-326, 2000.
GABAergic neurotransmission in globus pallidus and its involvement in neurologic disorders, Sheng Li Xue Bao, vol.56, issue.4, pp.427-462, 2004. ,
Peripheral inflammatory biomarkers and risk of Parkinson's disease, Am J Epidemiol, vol.167, pp.90-95, 2007. ,
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease, Ann Neurol, vol.58, pp.963-67, 2005. ,
Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3, Neurotox Res, vol.16, issue.4, pp.361-71, 2009. ,
Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model, Mol Neurobiol, vol.49, issue.3, pp.1282-92, 2014. ,
Design and evaluation of levodopa methyl ester intranasal delivery systems, J Parkinsons Dis, vol.1, issue.1, pp.101-108, 2011. ,
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease, Nat Rev Neurosci, vol.11, issue.12, pp.791-798, 2010. ,
On deaf ears, Mycobacterium avium paratuberculosis in pathogenesis Crohn's and other diseases, World J Gastroenterol, vol.21, issue.48, pp.13411-13418, 2015. ,
Changing views of basal ganglia circuits and circuit disorders, Clin EEG Neurosci, vol.41, issue.2, pp.61-68, 2010. ,
Les stratégies du traitement antiparkinsonien, Rev Prat, vol.55, issue.7, pp.723-731, 2005. ,
Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease, Biochim Biophys Acta, 2013. ,
Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and co-morbidities: role of gastrointestinal microbiota, J Neurovirol, vol.22, issue.1, pp.22-32, 2016. ,
paratuberculosis and Parkinson's disease-is this a trigger, Med Hypotheses, vol.83, issue.6, pp.709-721, 2014. ,
Évolution des connaissances sur le processus pathologique de la maladie de Parkinson, Bull. Acad. Natle Méd, vol.194, issue.7, pp.1287-1304, 2010. ,
CNS infections, sepsis and risk of Parkinson's disease, Int J Epidemiol, vol.41, issue.4, pp.1042-1051, 2012. ,
Gastrointestinal dysfunction in Parkinson's disease, Lancet Neurol, vol.14, issue.6, pp.625-664, 2015. ,
Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease, Mov Disord, vol.7, issue.2, pp.153-161, 1992. ,
Update on Parkinson disease, Cleve Clin J Med, vol.82, issue.9, pp.563-571, 2015. ,
A systematic review on drugs absorption modifications after eradication in Helicobacter pylori positive patients undergoing replacement therapy, J Gastrointestin Liver Dis, vol.24, issue.1, pp.95-100, 2015. ,
Use of ibuprofen and risk of Parkinson disease, Neurology, vol.76, pp.863-69, 2011. ,
Genetics of Parkinson's disease, Dialogues Clin Neurosci, vol.6, issue.3, pp.295-301, 2004. ,
Isoniazid therapy in Parkinson's disease, Mov Disord, vol.3, issue.2, pp.133-142, 1988. ,
Mortality and hallucinations in nursing home patients with advanced Parkinson's disease, Neurology, vol.45, pp.669-671, 1995. ,
Protective effect of vagotomy suggests source organ for Parkinson disease, Ann Neurol, vol.78, issue.5, pp.834-839, 2015. ,
Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations, Antimicrob Agents Chemother, 2007. ,
Association of Parkinson's disease with infections and occupational exposure to possible vectors, Mov Disord, vol.27, issue.9, pp.1111-1118, 2012. ,
Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease, PLoS One, vol.9, issue.11, p.112330, 2014. ,
Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model, Behav Brain Res, vol.268, pp.177-84, 2014. ,
Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders, Int Neurourol J, vol.20, issue.1, pp.2-7, 2016. ,
Amantadine: the journey from fighting flu to treating Parkinson disease, Neurology, vol.78, issue.14, pp.1096-1105, 2012. ,
Ceftriaxone prevents and reverses behavioral and neuronal deficits in an MPTP-induced animal model of Parkinson's disease dementia, Neuropharmacology, vol.91, pp.43-56, 2015. ,
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease, Front Aging Neurosci, vol.6, p.213, 2014. ,
Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration, Proc Natl Acad Sci U S A, vol.106, issue.33, pp.14063-14071, 2009. ,
Smeyne RJ. (b) Viral parkinsonism, Biochim Biophys Acta, vol.1792, issue.7, pp.714-735, 2009. ,
Rapamycin protects the mitochondria against oxidative stress and apoptosis in a rat model of Parkinson's disease, Int J Mol Med, vol.31, issue.4, pp.825-857, 2013. ,
Targeting alpha-synuclein in Parkinson's disease, Chem Biol, 2004. ,
Cutting the vagal highway blocks one point of entry for prion-like alphasynuclein, Ann Neurol, vol.78, issue.4, pp.520-521, 2015. ,
Rifampicin inhibits neurodegeneration in the optic nerve transection model in vivo and after 1-methyl-4-phenylpyridinium intoxication in vitro, Acta Neuropathol, vol.108, issue.1, pp.65-73, 2004. ,
Reversible parkinsonism and dystonia following probable mycoplasma pneumoniae infection, Mov Disord, vol.10, issue.4, pp.510-512, 1995. ,
The Role of Oxidative Stress in Neurodegenerative Diseases, Exp Neurobiol, vol.24, issue.4, pp.325-365, 2015. ,
Circulating antibody to Nocardia in the serum of patients with Parkinson's disease, Adv Neurol, vol.60, pp.355-362, 1993. ,
Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease, J Neurosci Res, vol.91, issue.10, pp.1292-302, 2013. ,
Systematic review: Helicobacter pylori infection and impaired drug absorption, Aliment Pharmacol Ther, vol.29, issue.4, pp.379-86, 2009. ,
Helicobacter pylori infection and drugs malabsorption, World J Gastroenterol, vol.20, issue.30, pp.10331-10338, 2014. ,
Functional Neuroanatomy of the Basal Ganglia, Cold Spring Harb Perspect Med, vol.2, issue.12, p.9621, 2012. ,
Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model, Glia, vol.61, issue.7, pp.1084-100, 2013. ,
Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats, ACS Chem Neurosci, vol.3, issue.1, pp.22-30, 2012. ,
Parkinson's disease: aetiology, diagnosis, and management, Hong Kong Med J, vol.11, issue.6, pp.476-89, 2005. ,
Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils, Chem Biol, vol.11, issue.11, pp.1513-1534, 2004. ,
Redox Imbalance and Viral Infections in Neurodegenerative Diseases, Oxid Med Cell Longev, p.6547248, 2016. ,
The etiopathogenesis of Parkinson disease and suggestions for future research. Part I, J Neuropathol Exp Neurol, vol.66, issue.4, pp.251-258, 2007. ,
?-synuclein, LRRK2 and their interplay in Parkinson's disease, Future Neurol, vol.7, issue.2, pp.145-153, 2012. ,
Early-Life Factors and Risk of Parkinson's Disease: A Register-Based Cohort Study, PLoS One, vol.11, issue.4, p.152841, 2016. ,
Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation, Environ Health Perspect, vol.111, issue.8, pp.1065-73, 2003. ,
Advances with microRNAs in Parkinson's disease research, Drug Des Devel Ther, vol.7, pp.1103-1116, 2013. ,
Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's DiseaseLessons from Transgenic Mice, Int J Mol Sci, vol.17, issue.2, p.151, 2016. ,
Type-1 interferons contribute to the neuroinflammatory response and disease progression of the MPTP mouse model of Parkinson's disease, Glia, vol.64, issue.9, pp.1590-604, 2016. ,
RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation, J Neurosci, vol.26, issue.39, pp.9996-10005, 2006. ,
Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease, J Neurosci, vol.30, issue.3, pp.1166-75, 2010. ,
The ubiquitin ligase parkin mediates resistance to intracellular pathogens, Nature, vol.501, issue.7468, pp.512-518, 2013. ,
Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis, J Neurol Neurosurg Psychiatry, vol.51, issue.6, pp.753-759, 1988. ,
The probable relation between Toxoplasma gondii and Parkinson's disease, Neurosci Lett, vol.475, issue.3, pp.129-160, 2010. ,
Parkinsonism with HIV infection, Mov Disord, 1998. ,
Brain-gut-microbiota axis in Parkinson's disease, World J Gastroenterol, vol.21, issue.37, pp.10609-10629, 2015. ,
Parallel manifestations of neuropathologies in the enteric and central nervous systems, Neurogastroenterol Motil, vol.23, issue.12, pp.1056-65, 2011. ,
Treatment for Helicobacter pylori infection and risk of Parkinson's disease in Denmark, Eur J Neurol, vol.19, issue.6, pp.864-873, 2012. ,
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease, Neurology, vol.66, issue.5, pp.664-71, 2006. ,
A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results, Clin Neuropharmacol, vol.31, issue.3, pp.141-50, 2008. ,
Movement disorders due to cerebral Toxoplasma gondii infection in patients with the acquired immunodeficiency syndrome (AIDS) ,
, Acta Neurol Belg, vol.92, issue.3, pp.148-56, 1992.
A rat model of Parkinson's disease induced by Japanese encephalitis virus, J Neurovirol, vol.3, issue.2, pp.141-148, 1997. ,
Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain, Brain Res, 2006. ,
DOI : 10.1016/j.brainres.2006.01.116
Amantadine for dyskinesia in patients affected by severe Parkinson's disease, Neurol Sci, vol.22, issue.1, pp.75-81, 2001. ,
DOI : 10.1007/s100720170054
Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect, Br J Clin Pharmacol, vol.3, issue.5, pp.883-892, 1976. ,
Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study), Mov Disord, vol.30, issue.6, pp.788-95, 2015. ,
Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement, Neurobiol Dis, 2008. ,
Rapamycin protects against rotenoneinduced apoptosis through autophagy induction, Neuroscience, vol.164, issue.2, pp.541-51, 2009. ,
DOI : 10.1016/j.neuroscience.2009.08.014
An essay on the shaking palsy 1817, J Neuropsychiatry Clin Neurosci, vol.14, issue.2, pp.223-259, 2002. ,
An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future, Antimicrob Agents Chemother, vol.55, issue.1, pp.24-34, 2011. ,
DOI : 10.1128/aac.00749-10
URL : https://aac.asm.org/content/55/1/24.full.pdf
Mitophagy and the mitochondrial unfolded protein response in neurodegeneration and bacterial infection, BMC Biol, vol.13, p.22, 2015. ,
Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson's disease patients, Neurol Sci, vol.22, issue.1, pp.89-91, 2001. ,
DOI : 10.1007/s100720170061
Transcient improvement of extrapyramidal syndrome after general anaesthesia, Ann Fr Anesth Reanim, vol.31, issue.3, pp.251-255, 2012. ,
Can Parkinson's Disease Come From the Gut?, Mov Disord, vol.30, issue.10, p.1325, 2015. ,
Scrub typhus mimicking Parkinson's disease, BMC Res Notes, vol.8, p.438, 2015. ,
DOI : 10.1186/s13104-015-1428-x
URL : https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-015-1428-x
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration, Glia, vol.55, pp.453-62, 2007. ,
DOI : 10.1002/glia.20467
URL : http://europepmc.org/articles/pmc2871685?pdf=render
Treatment with diazepam of children with drug-induced extrapyramidal symptoms, S Afr Med J, vol.55, issue.9, pp.328-358, 1979. ,
Dopamine Receptors and Neurodegeneration, Aging Dis, vol.6, issue.5, pp.349-68, 2015. ,
DOI : 10.14336/ad.2015.0330
URL : http://www.aginganddisease.org/EN/article/downloadArticleFile.do?attachType=PDF&id=147472
A rare case of tuberculosis with motor neuron disease, World J Surg Oncol, vol.12, p.381, 2014. ,
Nitrated alphasynucleinactivated microglial profiling for Parkinson's disease, Journal of Neurochemistry, vol.104, issue.6, pp.1504-1525, 2008. ,
DOI : 10.1111/j.1471-4159.2007.05087.x
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1471-4159.2007.05087.x
Helicobacter pylori infection as a cause of extra-digestive diseases: myth or reality?, Gastroenterol Clin Biol, vol.27, issue.3, pp.459-66, 2003. ,
Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies, Biomed Res Int, p.628192, 2015. ,
Immunolocalization of influenza A virus and markers of inflammation in the human Parkinson's disease brain, PLoS One, vol.6, issue.5, p.20495, 2011. ,
Betalactam antibiotics offer neuroprotection by increasing glutamate transporter expression, Nature, vol.433, issue.7021, pp.73-80, 2005. ,
Ceftriaxone blocks the polymerization of ?-synuclein and exerts neuroprotective effects in vitro, ACS Chem Neurosci, vol.5, issue.1, pp.30-38, 2014. ,
Ubiquilin 1 Promotes IFN-?-Induced Xenophagy of Mycobacterium tuberculosis, PLoS Pathog, vol.11, issue.7, p.1005076, 2015. ,
Genetics of leprosy: expected and unexpected developments and perspectives, Clin Dermatol, vol.33, issue.1, pp.99-107, 2015. ,
,
Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial, PLoS One, vol.5, issue.12, p.15298, 2010. ,
Protective and toxic roles of dopamine in Parkinson's disease, J Neurochem, vol.129, issue.6, pp.898-915, 2014. ,
Role of ?-and ?-Synucleins in the Axonal Pathology of Parkinson's Disease and Related Synucleinopathies, Biomolecules, 2015. ,
, Pharmactuel, vol.33, issue.2, pp.67-74, 2000.
Association Between Tuberculosis and Parkinson Disease: A Nationwide, Population-Based Cohort Study, Medicine (Baltimore), vol.95, issue.8, p.2883, 2016. ,
Olfactory nerve-a novel invasion route of Neisseria meningitidis to reach the meninges, PLoS One, vol.5, issue.11, p.14034, 2010. ,
La famille des récepteurs de la dopamine, médecine/sciences, vol.1, issue.9, pp.12-20, 1993. ,
Vagotomy and subsequent risk of Parkinson's disease, Ann Neurol, 2015. ,
The substantia nigra is a major target for neurovirulent influenza A virus, J Exp Med, vol.181, issue.6, pp.2161-2170, 1995. ,
Viral etiology for Parkinson's disease-a possible role of influenza A virus infection, Jpn J Infect Dis, vol.52, issue.3, pp.89-98, 1999. ,
Helicobacter pylori infection is associated with worse severity of Parkinson's disease, Parkinsonism Relat Disord, vol.21, issue.3, pp.221-226, 2015. ,
Effect of Fragmented Pathogenic ?-Synuclein Seeds on Prion-like Propagation, J Biol Chem, vol.291, issue.36, pp.18675-88, 2016. ,
Recent discoveries on the function and plasticity of central dopamine pathways, Med Sci, vol.26, issue.2, pp.165-70, 2010. ,
Duration of amantadine benefit on dyskinesia of severe Parkinson's disease, J Neurol Neurosurg Psychiatry, vol.75, issue.1, pp.141-144, 2004. ,
Minocycline: neuroprotective mechanisms in Parkinson's disease, Curr Pharm Des, vol.10, issue.b, pp.679-86, 2004. ,
Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro, Biochem Biophys Res Commun, vol.204, issue.1, pp.76-83, 1994. ,
Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger, J Biol Chem, vol.271, issue.12, pp.6839-6883, 1996. ,
Hepatitis C virus infection as a risk factor for Parkinson disease: A nationwide cohort study, Neurology, vol.86, issue.9, pp.840-846, 2016. ,
Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy, Neuroreport, vol.19, issue.13, pp.1271-1277, 2008. ,
Rifampicin is a candidate preventive medicine against amyloid-? and tau oligomers, Brain, vol.139, issue.5, pp.1568-86, 2016. ,
Alpha-synuclein Toxicity in the Early Secretory Pathway: How It Drives Neurodegeneration in Parkinsons Disease, Front Neurosci, vol.9, p.433, 2015. ,
Protective effects of doxycycline upon dopaminergic neuron in LPS-induced rat model of Parkinson's disease, Zhonghua Yi Xue Za Zhi, vol.89, p.1346, 2009. ,
Hepatitis C virus infection: a risk factor for Parkinson's disease, J Viral Hepat, vol.23, issue.7, p.535, 2016. ,
Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment, Gut, vol.55, issue.11, pp.1624-1654, 2006. ,
Parkinson's disease-Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment, Am J Manag Care, vol.14, issue.2, pp.40-48, 2008. ,
A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease, Mov Disord, vol.10, issue.5, pp.664-671, 1995. ,
Systemic BCG infection in a patient with pancytopaenia and fever 9 years after intravesical BCG administration for bladder cancer, BMJ Case Rep, 2016. ,
Inflammation as a causative factor in the aetiology of Parkinson's disease, Br J Pharmacol, vol.150, issue.8, pp.963-76, 2007. ,
Helicobacter pylori-does it only cause gastroduodenal disease?, Pol Merkur Lekarski, vol.11, issue.65, pp.456-465, 2001. ,
Hepatitis C virus infection: a risk factor for Parkinson's disease, J Viral Hepat, vol.22, issue.10, pp.784-91, 2015. ,
Fecal microbiota transplantation broadening its application beyond intestinal disorders, World J Gastroenterol, vol.21, issue.1, pp.102-113, 2015. ,
Neonatal Bacillus Calmette-Guérin vaccination alleviates lipopolysaccharide-induced neurobehavioral impairments and neuroinflammation in adult mice, Mol Med Rep, vol.14, issue.2, pp.1574-86, 2016. ,
BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease, PLoS One, vol.6, issue.1, p.16610, 2011. ,
The potential of minocycline for neuroprotection in human neurologic disease, Clin Neuropharmacol, vol.27, issue.6, pp.293-301, 2004. ,
Viruses and neurodegeneration, Synopsis des récepteurs dopaminergiques (d'après Sokoloff, vol.10, 1993. ,
Annexe 2 : Voies de signalisation intracellulaire des récepteurs dopaminergiques de la famille D1 (d'après Ranger, 2015. ,
Voies de signalisation intracellulaire des récepteurs dopaminergiques de la famille D2 (d'après Ranger, Annexe, vol.3, 2015. ,